pGM169/GL67A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pGM169/GL67A, covering 2020-01-18 to 2020-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Single Dose of pGM169/GL67A in CF Patients [Phase 1, Phase 2]